touchPODCAST touchpodcast

touchPANEL DISCUSSION for touchONCOLOGY 
Listen to a panel of leading experts discuss the latest evidence and clinical implications of recently approved treatments for relapsed/refractory follicular lymphoma (R/R FL), the importance of shared decision-making in treatment selection in the era of BsAb and CAR T-cell therapies, and the key considerations for treatment sequencing. 
The experts
Dr Matthew Lunning, University of Nebraska, Omaha, NE, USA,
Professor Charalambos Andreadis, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA,
Dr Tara Graff, Mission Cancer and Blood, Des Moines, IA, USA.
This touchPODCAST is for HCPs only. 
This activity is funded by an independent medical education grant from Bristol Myers Squibb and is jointly provided by USF Health and touchIME.
For further information visit: https://touchoncologyime.org/evolving-treatment-paradigm-relapsed-refractory-follicular-lymphoma 

touchPANEL DISCUSSION for touchHAEMATOLOGY
Listen to a panel of leading experts discuss the latest evidence and clinical implications of recently approved treatments for relapsed/refractory follicular lymphoma (R/R FL), the importance of shared decision-making in treatment selection in the era of BsAb and CAR T-cell therapies, and the key considerations for treatment sequencing. 
The experts
Dr Matthew Lunning, University of Nebraska, Omaha, NE, USA,
Professor Charalambos Andreadis, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA,
Dr Tara Graff, Mission Cancer and Blood, Des Moines, IA, USA.
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Bristol Myers Squibb and is jointly provided by USF Health and touchIME.
For further information visit: https://touchhaematologyime.org/evolving-treatment-paradigm-relapsed-refractory-follicular-lymphoma
 

touchEXPERT OPINIONS for touchINFECTIOUS DISEASES
Listen to leading experts describe the HIV life cycle, the rationale for multidrug antiretroviral therapy (ART) regimens, mechanisms of ART resistance and how to manage it in people living with HIV.
The experts
Prof. Anne-Mieke Vandamme - Katholieke Universiteit Leuven, Leuven, Belgium
Prof. José Arribas - La Paz Hospital, Madrid, Spain
Prof. Antonella Castagna - Vita-Salute San Raffaele University, Milan, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Viiv Healthcare. This activity is provided by touchIME.
For further information visit our website: 
https://touchinfectiousdiseases.com/ 

touchIN CONVERSATION for touchRESPIRATORY
Listen to a medical oncologist and a pathologist as they discuss HER2 alterations in non-small cell lung cancer (NSCLC), including the different types of HER2 alterations, key considerations for HER2 testing and the latest data for HER2-targeting treatments. 
The experts
Prof. Enriqueta Felip - Medical Oncologist, Vall d'Hebron University Hospital, Barcelona, Spain
Prof. Keith Kerr - Aberdeen University Medical School and Aberdeen Royal Infirmary, Aberdeen, UK
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from AstraZeneca, and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website: 
https://touchrespiratoryime.org/her2_nsclc_testing_and_targeted_therapies/

touchIN CONVERSATION for touchONCOLOGY
Listen to a medical oncologist and a pathologist as they discuss HER2 alterations in non-small cell lung cancer (NSCLC), including the different types of HER2 alterations, key considerations for HER2 testing and the latest data for HER2-targeting treatments. 
The experts
Prof. Enriqueta Felip - Medical Oncologist, Vall d'Hebron University Hospital, Barcelona, Spain
Prof. Keith Kerr - Aberdeen University Medical School and Aberdeen Royal Infirmary, Aberdeen, UK
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from AstraZeneca, and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website: 
https://touchoncologyime.org/her2_nsclc_testing_and_targeted_therapies/
 

touchIN CONVERSATION for touchNEUROLOGY - Early diagnosis and treatment of NMOSD: Practical insights
Listen to a neurologist and a neuro-ophthalmologist, both renowned experts in neuromyelitis optica spectrum disorder (NMOSD), answer questions from the ophthalmology and neurology communities on the management of NMOSD. They discuss presenting symptoms, differential diagnoses, management of acute attacks and long-term treatment.
The experts:
Prof. John Chen - Mayo Clinic, Rochester, MN, USA
Prof. Friedemann Paul - Charité - Universitätsmedizin Berlin, Campus Mitte, Germany
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Horizon Therapeutics. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurologyime.org/nmosd_diagnosis_treatmenthttps://touchneurologyime.org/nmosd_diagnosis_treatment